Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease

Blood

Volumn 126, Issue 6, 2015, Pages 703-710

  Detterich, Jon A ^a   Kato, Roberta M ^b   Rabai, Miklos ^c   Meiselman, Herbert J ^a   Coates, Thomas D ^a   Wood, John C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

^c UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; BLOOD VESSEL FUNCTION; BLOOD VESSEL PARAMETERS; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATIONAL STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ETHNICITY; FEMALE; FLOW MEDIATED DILATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; SICKLE CELL ANEMIA; SYSTEMIC DISEASE; TREATMENT FAILURE; TRICUSPID REGURGITATION VELOCITY; YOUNG ADULT; ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD; BLOOD FLOW VELOCITY; CASE CONTROL STUDY; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART; HEMOLYSIS; LUNG; METABOLISM; PATHOPHYSIOLOGY; TRICUSPID VALVE REGURGITATION; VASCULAR ENDOTHELIUM; VASODILATATION; VISCOSITY;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD FLOW VELOCITY; BLOOD TRANSFUSION; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HEART; HEMOGLOBINS; HEMOLYSIS; HUMANS; HYPERTENSION, PULMONARY; LUNG; MALE; TRICUSPID VALVE INSUFFICIENCY; VASODILATION; VISCOSITY;

EID: 84940055132     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-12-614370     Document Type: Article

References (44)

1. Itano HA, Pauling L. A rapid diagnostic test for sickle cell anemia. Blood. 1949;4(1):66-68.
2. Pauling L, Itano HA, et al. Sickle cell anemia a molecular disease. Science. 1949;110(2865):543-548.
3. Ballas SK. Pain management of sickle cell disease. Hematol Oncol Clin North Am. 2005;19(5):785-802, v.
4. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325(1):11-16.
5. Kuypers FA. Hemoglobin S polymerization and red cell membrane changes. Hematol Oncol Clin North Am. 2014;28(2):155-179.
6. Belhassen L, Pelle G, Sediame S, et al. Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood. 2001;97(6):1584-1589.
7. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med. 2004;350(9):886-895.
8. Kato GJ, Gladwin MT, Steinberg MH. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 2007;21(1):37-47.
9. Kaul DK, Liu XD, Fabry ME, Nagel RL. Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol. 2000;278(6):H1799-H1806.
10. Hebbel RP. Reconstructing sickle cell disease: a data-based analysis of the "hyperhemolysis paradigm" for pulmonary hypertension from the perspective of evidence-based medicine. Am J Hematol. 2011;86(2):123-154.
11. Sinoway LI, Hendrickson C, Davidson WR Jr, Prophet S, Zelis R. Characteristics of flowmediated brachial artery vasodilation in human subjects. Circ Res. 1989;64(1):32-42.
12. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 1994;24(6):1468-1474.
13. Friedman D, Szmuszkovicz J, Rabai M, Detterich JA, Menteer J, Wood JC. Systemic endothelial dysfunction in children with idiopathic pulmonary arterial hypertension correlates with disease severity. J Heart Lung Transplant. 2012;31(6):642-647.
14. Alexy T, Pais E, Wenby RB, et al. Measurement of whole blood viscosity profiles via an automated viscometer: technical details and clinical relevance. Clin Lab. 2005;51(9-10):523-529.
15. Jan KM, Chien S. Effect of hematocrit variations on coronary hemodynamics and oxygen utilization. Am J Physiol. 1977;233(1):H106-H113.
16. Lopez L, Colan SD, Frommelt PC, et al. Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr. 2010;23(5):465-495; quiz 576-577.
17. Corretti MC, Anderson TJ, Benjamin EJ, et al International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257-265.
18. Peretz A, Leotta DF, Sullivan JH, et al. Flow mediated dilation of the brachial artery: an investigation of methods requiring further standardization. BMC Cardiovasc Disord. 2007;7:11.
19. Vogel RA, Corretti MC, Plotnick GD. A comparison of brachial artery flow-mediated vasodilation using upper and lower arm arterial occlusion in subjects with and without coronary risk factors. Clin Cardiol. 2000;23(8):571-575.
20. Fairbanks VF, Ziesmer SC, O'Brien PC. Methods for measuring plasma hemoglobin in micromolar concentration compared. Clin Chem. 1992;38(1):132-140.
21. Reiter CD, Wang X, Tanus-Santos JE, et al. Cellfree hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8(12):1383-1389.
22. Minneci PC, Deans KJ, Zhi H, et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest. 2005;115(12):3409-3417.
23. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA. 2005;293(13):1653-1662.
24. Vinchi F, De Franceschi L, Ghigo A, et al. Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases. Circulation. 2013;127(12):1317-1329.
25. Morris CR, Kuypers FA, Lavrisha L, et al. A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica. 2013;98(9):1375-1382.
26. Field JJ, Nathan DG, Linden J. The role of adenosine signaling in sickle cell therapeutics. Hematol Oncol Clin North Am. 2014;28(2):287-299.
27. Kaul DK, Liu XD, Chang HY, Nagel RL, Fabry ME. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice. J Clin Invest. 2004;114(8):1136-1145.
28. Detterich J, Alexy T, Rabai M, et al. Low-shear red blood cell oxygen transport effectiveness is adversely affected by transfusion and further worsened by deoxygenation in sickle cell disease patients on chronic transfusion therapy. Transfusion. 2013;53(2):297-305.
29. Zhang J, Johnson PC, Popel AS. Effects of erythrocyte deformability and aggregation on the cell free layer and apparent viscosity of microscopic blood flows. Microvasc Res. 2009;77(3):265-272.
30. Solomon SB, Wang D, Sun J, et al. Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia. Blood. 2013;121(9):1663-1672.
31. Wang D, Cortés-Puch I, Sun J, et al. Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia. Transfusion. 2014;54(7):1712-1724.
32. Lezcano NE, Odo N, Kutlar A, Brambilla D, Adams RJ. Regular transfusion lowers plasma free hemoglobin in children with sickle-cell disease at risk for stroke. Stroke. 2006;37(6):1424-1426.
33. Sachdev V, Kato GJ, Gibbs JS, et al; Walk- PHASST Investigators. Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom. Circulation. 2011;124(13):1452-1460.
34. Detterich JA, Sangkatumvong S, Kato R, et al. Patients with sickle cell anemia on simple chronic transfusion protocol show sex differences for hemodynamic and hematologic responses to transfusion. Transfusion. 2013;53(5):1059-1068.
35. Gladwin MT, Schechter AN, Ognibene FP, et al. Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation. 2003;107(2):271-278.
36. Brittain JE, Hulkower B, Jones SK, et al. Placenta growth factor in sickle cell disease: association with hemolysis and inflammation. Blood. 2010;115(10):2014-2020.
37. Sundaram N, Tailor A, Mendelsohn L, et al. High levels of placenta growth factor in sickle cell disease promote pulmonary hypertension. Blood. 2010;116(1):109-112.
38. Simonneau G, Parent F. Pulmonary hypertension in patients with sickle cell disease: not so frequent but so different. Eur Respir J. 2012;39(1):3-4.
39. Kato GJ, Onyekwere OC, Gladwin MT. Pulmonary hypertension in sickle cell disease: relevance to children. Pediatr Hematol Oncol. 2007;24(3):159-170.
40. Batra AS, Acherman RJ, Wong WY, et al. Cardiac abnormalities in children with sickle cell anemia. Am J Hematol. 2002;70(4):306-312.
41. Lester LA, Sodt PC, Hutcheon N, Arcilla RA. Cardiac abnormalities in children with sickle cell anemia. Chest. 1990;98(5):1169-1174.
42. Humbert M, Morrell NW, Archer SL, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):13S-24S.
43. Irwin DC, Baek JH, Hassell K, et al. Hemoglobin-induced lung vascular oxidation, inflammation, and remodeling contribute to the progression of hypoxic pulmonary hypertension and is attenuated in rats with repeated-dose haptoglobin administration. Free Radic Biol Med. 2015;82:50-62.
44. Huntsman LL, Stewart DK, Barnes SR, Franklin SB, Colocousis JS, Hessel EA. Noninvasive Doppler determination of cardiac output in man. Clinical validation. Circulation. 1983;67(3):593-602.